A Novel Platform to Identify and Treat Transitional Age Youth With Alcohol Use Disorder
Award amount
$270,604Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ELEVATEU LLC
- Proposal award date
- 2023-08-15
- Contract end date
- 2024-07-31
- UEI
- E6ZGZWVVK244
- Solicitation number
- PA22-176
- Topic code
- 350
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Opioid Support and Risk Reduction Online Platform
- Recruitment Platform to match Researchers with Substance Using Participants
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Study of Transcutaneous Auricular Neurostimulation as a Treatment for Alcohol Use Disorder
- Characterization of a novel non-hallucinogenic psilocybin derivative for alcohol use disorder
- Modulation of PDE4B by Aptamers for the Treatment of Alcohol Use Disorder
- A virtual reality (VR) platform that counselors can use to enhance treatment techniques and improve outcomes among those with alcohol use disorder
- Development of an AI-assisted therapeutic discovery platform for Alcohol Use Disorders using an invertebrate model
Research funding history
3 SBIR/STTR records share this UEI (2019–2023). Reported award amounts total $734,164. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services